Navigation Links
Cantel Medical Corp. To Hold Conference call to Discuss Fourth Quarter and Fiscal 2008 Results
Date:10/2/2008

LITTLE FALLS, N.J., Oct. 2 /PRNewswire-FirstCall/ -- Cantel Medical Corp. (NYSE: CMN) will hold a conference call to discuss the Company's results for its fourth quarter and fiscal year ended July 31, 2008 on October 7, 2008 at 11:00 AM EDT. Participating in the call will be Charles M. Diker, Chairman; Andrew A. Krakauer, President; Seth R. Segel, Senior Vice President-Corporate Development and Strategy; Craig A. Sheldon, Senior Vice President and CFO; and Roy K. Malkin, President of Minntech Corporation. Minntech is a Cantel subsidiary. The fourth quarter and year end results will be announced on October 7 before the market opens.

To participate in the conference call, dial (877) 407-8035 approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Tuesday, October 7, 2008 at 2:00 PM through midnight on October 8, 2008 by dialing (877) 660-6853 and using pass code # 286 and conference ID # 298923.

The call will be simultaneously broadcast live over the Internet on vcall.com at http://www.investorcalendar.com/IC/CEPage.asp?ID=135448. A replay of the web cast will be available on Vcall for 30 days.

About Cantel Medical Corp.

Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Cantel's products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. Cantel also provides technical maintenance for its products and offers compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel website at http://www.cantelmedical.com.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary
2. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
3. NxStage Medical to Present at JMP Securities Healthcare Focus Conference
4. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
5. No Blood Needed Thanks to Innovative Medical Technology
6. China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
7. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
8. Fujitsu PalmSecure and HT Systems PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft
9. Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets
10. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
11. Varian Medical Systems Exhibits a New Version of RapidArc(TM) Radiotherapy Technology and Other Products for Fast, Precise Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
Breaking Biology News(10 mins):